Vinccent Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.45 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 43.24%
- Profit Growth 41.80%
- Ebitda -238.16%
- Net Worth 30.24%
- Total Assets 0.44%
About Vinccent Biotech
Vinccent Biotech Private Limited (VBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 March 2008 and has a history of 16 years and 11 months. Its registered office is in Delhi, Delhi, India.
The Corporate was formerly known as Nishnat Exim Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.45 M, as per Ministry of Corporate Affairs (MCA) records.
Raju Aggarwal and Deepti Aggarwal serve as directors at the Company.
Company Details
- Location
Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2008PTC174994
- Company No.
174994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vinccent Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raju Aggarwal  | Director | 05-Mar-2008 | Current |
| Deepti Aggarwal | Director | 20-Feb-2020 | Current |
Financial Performance of Vinccent Biotech.
Vinccent Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.24% increase. The company also saw a substantial improvement in profitability, with a 41.8% increase in profit. The company's net worth Soared by an impressive increase of 30.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinccent Biotech?
In 2023, Vinccent Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fair Deal Cars Private LimitedRaju Aggarwal is a mutual person
Fair Deal Wheels Private LimitedRaju Aggarwal and Deepti Aggarwal are mutual person
- N S N Biotech Private Limited
Raju Aggarwal is a mutual person
- Nitant Fabrications Private Limited
Raju Aggarwal is a mutual person
- Fair Deal Landmarks Private Limited
Deepti Aggarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vinccent Biotech?
Unlock and access historical data on people associated with Vinccent Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinccent Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinccent Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
